Anzeige
++++++ Spezial am Donnerstag – Neuer Anstoß, News und was die Börsencommunity jetzt nicht verpassen will… ++++++
Assertio Therapeutics WKN: A2N4B9 ISIN: US04545L1070 Kürzel: ASRT Branche:
k.A. % HL
Intervall: k.A.
High: k.A.
Low: k.A.
Börse: k.A.
k.A. % HL
Intervall: k.A.
High: k.A.
Low: k.A.
Börse: k.A.
k.A. % HL
Intervall: k.A.
High: k.A.
Low: k.A.
Börse: k.A.
k.A. % HL
Intervall: k.A.
High: k.A.
Low: k.A.
Börse: k.A.
k.A. % HL
Intervall: k.A.
High: k.A.
Low: k.A.
Börse: k.A.
k.A. % HL
Intervall: k.A.
High: k.A.
Low: k.A.
Börse: k.A.
k.A. % HL
Intervall: k.A.
High: k.A.
Low: k.A.
Börse: k.A.
k.A. % HL
Intervall: k.A.
High: k.A.
Low: k.A.
Börse: k.A.
Anzeige
Chemical,
DEPOMED
Hauptdiskussion, 11.05.2020 14:44 Uhr
Assertio Therapeutics EPS beats by $0.18, beats on revenue https://seekingalpha.com/news/3572647-assertio-therapeutics-eps-beats-0_18-beats-on-revenue
Chemical,
DEPOMED
Hauptdiskussion, 15.02.2020 8:29 Uhr
Assertio Therapeutics: A Biotech Stock Trading Below Its Cash Balance
https://seekingalpha.com/article/4324469-assertio-therapeutics-biotech-stock-trading-below-cash-balance
Takeaway
ASRT has seen its fair share of woes, from the recent rejection of its cosyntropin sNDA, to below-average data readout on collaboration project IW-3718, and to a staggering -20% Y/Y decline on core product revenues. On the other hand, the recent sale of Nucynta for $375M removes all remaining debt from the company's balance sheet, causes its stock to trade at negative enterprise value, and adds sizable capital for future R&D efforts. Keep in mind, ASRT is estimated to continue its profitability after the deal closes, as its remaining products have over 60-80% gross margin. Hence, the author finds the benefit to outweigh the company's drawbacks, and will reiterate the company's buy rating as of today.
Andymac0815,
DEPOMED
Hauptdiskussion, 06.02.2020 23:08 Uhr
Letztes Jahr mit Verlust raus 🤤
Chemical,
DEPOMED
Hauptdiskussion, 06.02.2020 22:04 Uhr
Assertio Therapeutics Announces Sale of NUCYNTA® Franchise to Collegium Pharmaceutical for $375.0 Million
https://newsfilter.io/a/3d0fa5d5f5e45ad603002142755aedb8
Billi1,
DEPOMED
Hauptdiskussion, 13.01.2020 15:43 Uhr
😎
Chemical,
DEPOMED
Hauptdiskussion, 13.01.2020 14:21 Uhr
👀
Chemical,
DEPOMED
Hauptdiskussion, 13.01.2020 14:20 Uhr
Assertio Therapeutics Sees FY19 Neurology Franchise Sales Above Guidance Range Of $102M-$105M
Chemical,
DEPOMED
Hauptdiskussion, 13.01.2020 14:19 Uhr
Assertio Therapeutics Announces Closing Of Gralise Sale To Alvogen; Co. To Receive $127.5M
Chemical,
DEPOMED
Hauptdiskussion, 28.12.2019 14:28 Uhr
Assertio pipeline products
https://www.assertiotx.com/products-and-pipeline/pipeline/
Zwei Medikamente stehen vor dem Approvel
Chemical,
DEPOMED
Hauptdiskussion, 27.12.2019 20:28 Uhr
Assertio (ASRT) Upgraded to Strong Buy: What Does It Mean for the Stock?
https://finance.yahoo.com/news/assertio-asrt-upgraded-strong-buy-170005299.html
The upgrade of Assertio to a Zacks Rank #1 positions it in the top 5% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the near term.
Chemical,
DEPOMED
Hauptdiskussion, 27.12.2019 20:26 Uhr
ASRT vs. PCRX: Which Stock Is the Better Value Option?
https://finance.yahoo.com/news/asrt-vs-pcrx-stock-better-164004569.html
ASRT sticks out from PCRX in both our Zacks Rank and Style Scores models, so value investors will likely feel that ASRT is the better option right now
FCINGO,
DEPOMED
Hauptdiskussion, 27.12.2019 14:15 Uhr
Karmate, was erwartet du hier ?
Karmate1,
DEPOMED
Hauptdiskussion, 26.12.2019 13:48 Uhr
Es geht los
Karmate1,
DEPOMED
Hauptdiskussion, 26.12.2019 13:47 Uhr
🚀
rationality,
DEPOMED
Hauptdiskussion, 13.12.2019 15:38 Uhr
Ich leider auch...
|
Themen zum Wert | ||
---|---|---|---|
1 | DEPOMED Hauptdiskussion |
Kursdetails
Geld (bid) | 0,735 (6.854) |
---|---|
Brief (ask/offer) | 0,755 (6.854) |
Spread | 2,649 |
Geh. Stück | 0 |
Eröffnung | 0,730 |
Vortag | 0,730 |
Tageshoch | 0,745 |
Tagestief | 0,730 |
52W Hoch | 0,000 |
52W Tief | 0,000 |
Tagesvolumen
in USD gehandelt | 1,1 Mio. Stk |
---|---|
Gesamt | 1,1 Mio. Stk |
Partner-News
Anzeige16:46 Uhr • Partner • Societe Generale
16:00 Uhr • Partner • BNP Paribas
15:00 Uhr • Partner • HSBC
14:35 Uhr • Partner • Societe Generale
14:20 Uhr • Partner • BNP Paribas
Aktien-News
17:24 Uhr • Artikel • dpa-AFX
17:13 Uhr • Meldungen • EQS News
17:12 Uhr • Meldungen • EQS News
17:04 Uhr • Meldungen • EQS News
17:00 Uhr • Meldungen • EQS News
Geld/Brief Kurse
Neu ladenBörse | Geld | Vol. | Brief | Vol. | Zeit | Vol. ges. | Kurs |
---|---|---|---|---|---|---|---|
Nasdaq | 0,791 | 3.400 Stk | 0,802 | 2.400 Stk | 1589940000 20. May | 1,1 Mio. Stk | 0,796 USD | ges. 1.143.184 Stk |
Realtime / Verzögert
Börsennotierung
Marktkapitalisierung in EUR |
---|
59,4 Mio. |
Anzahl der Aktien |
81,4 Mio. |